Stocks · Health care · Pharmaceutical Preparations

Avalo Therapeutics, Inc.

AVTX Clue Score19
United States Fiscal year ends December CIK 0001534120
$13.65 +1.64% Close, 9 Oct 2026

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
13.65 on 9 Oct 2026
23 18 13 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $13.67 14 Oct 2025 $13.99 15 Oct 2025 $13.90 16 Oct 2025 $14.00 17 Oct 2025 $15.35 20 Oct 2025 $17.08 21 Oct 2025 $17.43 22 Oct 2025 $15.78 23 Oct 2025 $17.92 24 Oct 2025 $17.57 27 Oct 2025 $17.99 28 Oct 2025 $18.38 29 Oct 2025 $18.04 30 Oct 2025 $18.04 31 Oct 2025 $18.03 3 Nov 2025 $16.67 4 Nov 2025 $16.09 5 Nov 2025 $16.45 6 Nov 2025 $15.42 7 Nov 2025 $15.05 10 Nov 2025 $15.22 11 Nov 2025 $15.50 12 Nov 2025 $15.43 13 Nov 2025 $14.73 14 Nov 2025 $15.11 17 Nov 2025 $16.88 18 Nov 2025 $18.00 19 Nov 2025 $17.59 20 Nov 2025 $17.74 21 Nov 2025 $17.83 24 Nov 2025 $18.00 25 Nov 2025 $18.99 26 Nov 2025 $18.55 28 Nov 2025 $19.00 1 Dec 2025 $16.78 2 Dec 2025 $15.87 3 Dec 2025 $16.97 4 Dec 2025 $17.95 5 Dec 2025 $17.56 8 Dec 2025 $19.44 9 Dec 2025 $19.24 10 Dec 2025 $19.95 11 Dec 2025 $19.51 12 Dec 2025 $18.60 15 Dec 2025 $17.70 16 Dec 2025 $18.82 17 Dec 2025 $19.25 18 Dec 2025 $18.91 19 Dec 2025 $18.60 22 Dec 2025 $19.17 23 Dec 2025 $18.67 24 Dec 2025 $18.91 26 Dec 2025 $18.37 29 Dec 2025 $18.56 30 Dec 2025 $17.81 31 Dec 2025 $18.16 2 Jan 2026 $17.02 5 Jan 2026 $16.03 6 Jan 2026 $15.91 7 Jan 2026 $16.94 8 Jan 2026 $17.11 9 Jan 2026 $16.95 12 Jan 2026 $16.67 13 Jan 2026 $17.20 14 Jan 2026 $16.19 15 Jan 2026 $15.64 16 Jan 2026 $15.06 20 Jan 2026 $14.80 21 Jan 2026 $15.76 22 Jan 2026 $16.25 23 Jan 2026 $15.75 26 Jan 2026 $15.65 27 Jan 2026 $16.06 28 Jan 2026 $14.97 29 Jan 2026 $15.25 30 Jan 2026 $15.11 2 Feb 2026 $15.65 3 Feb 2026 $15.96 4 Feb 2026 $14.37 5 Feb 2026 $13.15 6 Feb 2026 $14.19 9 Feb 2026 $14.01 10 Feb 2026 $14.61 11 Feb 2026 $14.35 12 Feb 2026 $14.40 13 Feb 2026 $14.26 17 Feb 2026 $15.07 18 Feb 2026 $15.00 19 Feb 2026 $15.97 20 Feb 2026 $14.21 23 Feb 2026 $14.80 24 Feb 2026 $16.20 25 Feb 2026 $16.86 26 Feb 2026 $17.64 27 Feb 2026 $17.50 2 Mar 2026 $17.98 3 Mar 2026 $18.85 4 Mar 2026 $18.36 5 Mar 2026 $17.58 6 Mar 2026 $17.31 9 Mar 2026 $17.31 10 Mar 2026 $16.93 11 Mar 2026 $17.10 12 Mar 2026 $16.71 13 Mar 2026 $15.80 16 Mar 2026 $16.02 17 Mar 2026 $15.38 18 Mar 2026 $14.68 19 Mar 2026 $14.22 20 Mar 2026 $13.42 23 Mar 2026 $13.50 24 Mar 2026 $13.45 25 Mar 2026 $13.95 26 Mar 2026 $13.95 27 Mar 2026 $13.89 30 Mar 2026 $13.93 31 Mar 2026 $14.93 1 Apr 2026 $16.70 2 Apr 2026 $17.76 6 Apr 2026 $16.27 7 Apr 2026 $15.92 8 Apr 2026 $14.41 9 Apr 2026 $14.21 10 Apr 2026 $13.66 13 Apr 2026 $13.34 14 Apr 2026 $13.90 15 Apr 2026 $13.35 16 Apr 2026 $14.42 17 Apr 2026 $14.43 20 Apr 2026 $14.66 21 Apr 2026 $14.29 22 Apr 2026 $14.50 23 Apr 2026 $14.75 24 Apr 2026 $13.92 27 Apr 2026 $14.42 28 Apr 2026 $12.86 29 Apr 2026 $13.20 30 Apr 2026 $13.40 1 May 2026 $13.71 4 May 2026 $13.78 5 May 2026 $16.26 6 May 2026 $21.81 7 May 2026 $22.87 8 May 2026 $21.57 11 May 2026 $20.25 12 May 2026 $19.94 13 May 2026 $19.85 14 May 2026 $19.01 15 May 2026 $17.74 18 May 2026 $16.16 19 May 2026 $16.27 20 May 2026 $16.29 21 May 2026 $16.60 22 May 2026 $16.35 26 May 2026 $16.02 27 May 2026 $15.79 28 May 2026 $16.13 29 May 2026 $15.95 1 Jun 2026 $15.75 2 Jun 2026 $13.96 3 Jun 2026 $13.74 4 Jun 2026 $13.61 5 Jun 2026 $13.10 8 Jun 2026 $12.74 9 Jun 2026 $12.90 10 Jun 2026 $13.10 11 Jun 2026 $13.67 12 Jun 2026 $14.76 15 Jun 2026 $14.60 16 Jun 2026 $14.33 17 Jun 2026 $15.40 18 Jun 2026 $14.70 22 Jun 2026 $17.08 23 Jun 2026 $17.83 24 Jun 2026 $18.16 25 Jun 2026 $18.00 26 Jun 2026 $18.20 29 Jun 2026 $19.29 30 Jun 2026 $18.48 1 Jul 2026 $17.29 2 Jul 2026 $18.84 6 Jul 2026 $19.96 7 Jul 2026 $19.25 8 Jul 2026 $19.21 9 Jul 2026 $19.95 10 Jul 2026 $19.21 13 Jul 2026 $18.91 14 Jul 2026 $18.42 15 Jul 2026 $18.55 16 Jul 2026 $17.88 17 Jul 2026 $19.37 20 Jul 2026 $18.21 21 Jul 2026 $18.82 22 Jul 2026 $18.15 23 Jul 2026 $17.76 24 Jul 2026 $18.44 27 Jul 2026 $19.50 28 Jul 2026 $19.52 29 Jul 2026 $19.01 30 Jul 2026 $19.39 31 Jul 2026 $18.25 3 Aug 2026 $18.05 4 Aug 2026 $18.53 5 Aug 2026 $18.84 6 Aug 2026 $18.70 7 Aug 2026 $18.32 10 Aug 2026 $19.77 11 Aug 2026 $19.47 12 Aug 2026 $19.55 13 Aug 2026 $19.45 14 Aug 2026 $19.59 17 Aug 2026 $19.95 18 Aug 2026 $19.71 19 Aug 2026 $20.75 20 Aug 2026 $19.82 21 Aug 2026 $19.83 24 Aug 2026 $19.27 25 Aug 2026 $19.74 26 Aug 2026 $20.55 27 Aug 2026 $20.05 28 Aug 2026 $19.59 31 Aug 2026 $19.34 1 Sep 2026 $18.95 2 Sep 2026 $19.34 3 Sep 2026 $19.00 4 Sep 2026 $19.23 8 Sep 2026 $19.71 9 Sep 2026 $18.21 10 Sep 2026 $17.18 11 Sep 2026 $16.12 14 Sep 2026 $16.18 15 Sep 2026 $16.07 16 Sep 2026 $16.58 17 Sep 2026 $16.69 18 Sep 2026 $16.57 21 Sep 2026 $16.17 22 Sep 2026 $16.51 23 Sep 2026 $15.30 24 Sep 2026 $15.72 25 Sep 2026 $15.47 28 Sep 2026 $15.08 29 Sep 2026 $15.58 30 Sep 2026 $15.33 1 Oct 2026 $14.95 2 Oct 2026 $14.99 5 Oct 2026 $14.60 6 Oct 2026 $13.59 7 Oct 2026 $13.58 8 Oct 2026 $13.43 9 Oct 2026 $13.65 Goldman Jonathan Director Sold at will $162.94K 14 Nov 2025 · at $14.33 · 100% of stake Doyle Mittie Chief Medical Officer Sold on a plan $411.61K 16 Mar 2026 · at $16.15 · 87.6% of stake Doyle Mittie Chief Medical Officer Sold on a plan $10.86K 1 Apr 2026 · at $16.00 · 15.8% of stake Sullivan Christopher Ryan Chief Financial Officer Sold on a plan $133.77K 1 Apr 2026 · at $16.77 · 24.0% of stake Sullivan Christopher Ryan Chief Financial Officer Sold on a plan $136.82K 2 Apr 2026 · at $17.15 · 31.5% of stake Doyle Mittie Chief Medical Officer Sold on a plan $71.51K 6 Apr 2026 · at $18.01 · 52.3% of stake Sullivan Christopher Ryan Chief Financial Officer Sold on a plan $110.74K 29 Apr 2026 · at $13.09 · 48.8% of stake Sullivan Christopher Ryan Chief Financial Officer Sold on a plan $111.85K 30 Apr 2026 · at $13.23 · 95.2% of stake Doyle Mittie Chief Medical Officer Sold on a plan $26.86K 5 May 2026 · at $16.00 · 31.7% of stake Chan Mitchell Director Sold on a plan $72.46K 6 May 2026 · at $22.88 · 50.0% of stake Sullivan Christopher Ryan Chief Financial Officer Sold on a plan $948.72K 6 May 2026 · at $20.19 · 99.1% of stake VARKI PAUL Chief Legal Officer Sold on a plan $1.51M 6 May 2026 · at $20.17 · 95.4% of stake Doyle Mittie Chief Medical Officer Sold on a plan $2.20M 6 May 2026 · at $20.68 · 96.7% of stake Sullivan Christopher Ryan Chief Financial Officer Sold on a plan $448.82K 7 May 2026 · at $24.12 · 97.8% of stake Doyle Mittie Chief Medical Officer Sold on a plan $56.28K 15 May 2026 · at $18.76 · 45.3% of stake Doyle Mittie Chief Medical Officer Sold on a plan $10.86K 28 May 2026 · at $16.00 · 1.4% of stake Doyle Mittie Chief Medical Officer Sold on a plan $26.10K 23 Jun 2026 · at $18.00 · 2.7% of stake Doyle Mittie Chief Medical Officer Sold on a plan $93.08K 30 Jun 2026 · at $20.00 · 8.2% of stake Doyle Mittie Chief Medical Officer Sold on a plan $20.00K 27 Jul 2026 · at $20.00 · 1.9% of stake Doyle Mittie Chief Medical Officer Sold on a plan $13.58K 10 Aug 2026 · at $20.00 · 1.3% of stake Riley Jennifer Chief Strategy Officer Sold at will $52.01K 11 Aug 2026 · at $19.59 · 6.7% of stake Doyle Mittie Chief Medical Officer Sold on a plan $20.00K 17 Aug 2026 · at $20.00 · 1.9% of stake Sullivan Christopher Ryan Chief Financial Officer Sold on a plan $828.10K 17 Aug 2026 · at $19.86 · 51.1% of stake Sullivan Christopher Ryan Chief Financial Officer Sold on a plan $622.32K 18 Aug 2026 · at $20.05 · 43.7% of stake Doyle Mittie Chief Medical Officer Sold on a plan $13.58K 28 Aug 2026 · at $20.00 · 1.3% of stake Sullivan Christopher Ryan Chief Financial Officer Sold on a plan $179.46K 10 Sep 2026 · at $17.62 · 20.3% of stake Sullivan Christopher Ryan Chief Financial Officer Sold on a plan $202.44K 16 Sep 2026 · at $16.33 · 23.7% of stake
0 buys2 sales at will25 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$59.00K
Net income
$78.26M
Free cash flow
$51.46M
Operating margin
-123,601.7%
Net margin
-132,642.4%
Return on equity
-94.2%
Return on capital
-58.6%
Debt to equity
0.18
Revenue growth, 1 yr
-86.6%
Revenue growth, 5 yr
-61.2% a year

Revenue and profit

Fiscal years, as filed with the SEC · point at a year for the detail
Full statements →
7M -64M FY20 Fiscal year 2020 Revenue $6.70M Net income $63.50M Margin -947.9% 5M -84M FY21 Fiscal year 2021 Revenue $5.40M Net income $84.38M Margin -1,563.1% · growth -19.4% 18M -42M FY22 Fiscal year 2022 Revenue $18.05M Net income $41.66M Margin -230.8% · growth +234.4% 2M -32M FY23 Fiscal year 2023 Revenue $1.92M Net income $31.54M Margin -1,639.5% · growth -89.3% 441K -35M FY24 Fiscal year 2024 Revenue $441.00K Net income $35.13M Margin -7,965.8% · growth -77.1% 59K -78M FY25 Fiscal year 2025 Revenue $59.00K Net income $78.26M Margin -132,642.4% · growth -86.6%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
16 Sep 2026 Sullivan Christopher Ryan
Chief Financial Officer
Sold on a plan $202.44K 23.7%
10 Sep 2026 Sullivan Christopher Ryan
Chief Financial Officer
Sold on a plan $179.46K 20.3%
28 Aug 2026 Doyle Mittie
Chief Medical Officer
Sold on a plan $13.58K 1.3%
18 Aug 2026 Sullivan Christopher Ryan
Chief Financial Officer
Sold on a plan $622.32K 43.7%
17 Aug 2026 Sullivan Christopher Ryan
Chief Financial Officer
Sold on a plan $828.10K 51.1%
17 Aug 2026 Doyle Mittie
Chief Medical Officer
Sold on a plan $20.00K 1.9%